Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062984 · ClinicalTrials.gov registry record · NA
Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01062984: Completed NA study, sponsored by University of Chicago.
NCT01062984 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01062984, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Acute kidney injury is often treated with the use of continuous renal replacement therapy. Two commonly used treatments are continuous venvenous hemofiltration (CVVH)and continuous venovenous hemodialysis (CVVHD). CVVH uses convective clearance to remove toxins and solutes from the patients circulation, while CVVHD relies on diffusive clearance to remove these same toxins/solutes. This study will evaluate which of these two methods is more effective at clearing the body of waste/solutes. We hypothesize that renal replacement therapy by either modality (hemodialysis or hemofiltration; CVVHD or CVVH, respectively) using a modern membrane and higher blood flow rates will be associated with similar clearances of both small and middle molecular weight solutes. We further believe that continuous renal replacement therapy using CVVHD will be associated with decreased clotting events and longer hemofilter survival, as well as improved resource utilization (i.e. nursing time, alarms, etc.).
Interventions
- PROCEDURE Continuous Venovenous Hemofiltration (CVVH)
- PROCEDURE Continuous Venovenous Hemodialysis (CVVHD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-01 |
| Est. Completion | 2022-10-25 |
| Phase | NA |
What the finished NCT01062984 record still lists
NCT01062984 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Continuous Venovenous Hemofiltration (CVVH) is the first listed.
NCT01062984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01062984 about?
NCT01062984 is a clinical study titled "Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis". Acute kidney injury is often treated with the use of continuous renal replacement therapy. Two commonly used treatments are continuous venvenous hemofiltration (CVVH)and continuous venovenous hemodialysis (CVVHD). CVVH uses convective clearance to remove toxins and solutes from the patients circulat...
What is the current status of trial NCT01062984?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2009-01. Estimated completion is 2022-10-25.
What interventions are being tested in trial NCT01062984?
The interventions under investigation include: Continuous Venovenous Hemofiltration (CVVH) (PROCEDURE), Continuous Venovenous Hemodialysis (CVVHD) (PROCEDURE).
Who is sponsoring clinical trial NCT01062984?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01062984's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia